MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
3 clinical trials · Sponsor
◉ Watch MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
| Record | Firm | Date |
|---|---|---|
| Progression of Cognitive and Physical Symptoms in Multiple Sclerosis (NCT00922831) | MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | 2008-08-01 |
| Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. (NCT00037115) | MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | 2002-05-01 |
| Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis (NCT00037102) | MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | 2001-07-01 |
Track MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute automatically
Every clearance here is in the API, with alerts when new ones post.